Keating Financial Advisory Services, Inc.
Position in NVO — Novo Nordisk A S
CIK 2103443
MANHATTAN, KS
Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$175,508
+$24,944 QoQ
Shares Held
3,661
-10.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,043
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keating Financial Advisory Services, Inc. holds $6,157,816 across 15 Drug Manufacturers - General names. NVO ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,236 | $1,482,495 | |
| 2 | JNJ |
Johnson & Johnson
|
5,631 | $1,430,105 | |
| 3 | ABBV |
AbbVie Inc.
|
4,827 | $1,214,666 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,606 | $591,871 | |
| 5 | AMGN |
Amgen Inc
|
1,289 | $466,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,783 | $351,604 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,379 | $194,697 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
3,661 | $175,508 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,508 | 3,661 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $150,564 | 4,097 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $146,432 | 2,878 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||